PARC Projects

Provide protection against most harmful chemicals
Shift away from animal testing
In vitro methods to assess respiratory uptake and toxicity
Human health
NGRA
Time span
-
Potential impacts
  • A guidance document on dosimetry and the use of respiratory in vitro models for uptake assessment;
  • Further development of a biokinetic model to determine respiratory uptake
  • Standardisation of methods to assess respiratory uptake with in vitro models
Partners involved
RIVM (NL)
INERIS (FR)
VITO (BE)
ENSP (PT)
LIST (LU)
IRFMN (IT)
STAMI (NO)
UG-PL (PL)
AUTH (GR)
WU-TOX (NL)
Contacts
Yvonne Staal (RIVM)
Yvonne.Staal [at] RIVM.nl
Tanja Hansen (Fraunhofer)
tanja.hansen [at] item.fraunhofer.de
Pierre-Andre Billat (INERIS)
Pierre-andre.BILLAT [at] ineris.fr
Media
Overview

Inhalation is an important but often not assessed route of chemical exposure, alongside dermal and oral pathways. This project addresses the current gap by developing in vitro models to assess how chemicals are absorbed, accumulated, and transported through respiratory tissues.

The focus is on two key chemical groups pesticides (e.g. pyrethroids) and per- and polyfluoroalkyl substances (PFAS) that are commonly encountered in occupational settings. Using data-rich chemicals with existing human in vivo data, the project will generate in vitro respiratory uptake data, develop biokinetic and QSAR models ↗, and refine physiologically based kinetic (PBK) models to estimate respiratory uptake. In vitro to in vivo extrapolation (IVIVE) ↗ will translate laboratory findings into real-world exposure levels.

This work aims to standardise in vitro respiratory models and dosimetry methods, enabling accurate evaluation of systemic effects from inhalation exposure. These advances will support regulatory risk assessments under frameworks such as REACH ↗ and OSHA, while contributing to reduced reliance on animal testing.

The project supports several PARC activities, including PFAS ↗ assessment, NAM ↗ development, endocrine disruptor mixtures, chronic toxicity modelling and read-across strategies. By delivering reliable tools and data, this initiative strengthens safety evaluations and enhances human health protection in industrial and environmental contexts.

Achievements & Results

The project has started in May 2025, the first activity is to identify data daps on air-liquid interface models’ dosimetry, in vitro biokinetic approaches and permeability models.

Policy relevance

This project will:

  • provide guidance for assessment of respiratory uptake of airborne substances;
  • enable regulatory implementation of NAM-based approaches focusing on inhaled exposure.
Filter by
Address chemical pollution in the natural environment
Provide protection against most harmful chemicals
Shift away from animal testing
Biodiversity protection
Promoting the circular economy through safe materials
Studying persistent, mobile and toxic chemicals in soil, water and air across Europe
Bridging data gaps for some Alternaria toxins
Environmental burden of disease and health impact of chemicals
Hazard characterization and closing data gaps of emerging mycotoxins
Innovative approaches to soil contaminant assessment
Risk assessment of chemical mixtures measured in the human body
Tools, criteria, and methods used in risk assessment reviews
Improving the transfer and use of information on chemicals in products
Total human exposure to chemicals from multiple sources and settings
Closing data gaps in PBK modelling for endocrine-disrupting chemicals (EDCs)
Effect-specific risk assessment reviews
Follow-up Immunotoxicity
Further development of an IATA for Metabolic Disruption
Improving computer models that simulate the behaviour of chemicals in the human body across different life stages
Integrated approaches to testing and assessment (IATA) for carcinogenicity
Making Adverse Outcome Pathways (AOPs) ready for use under EU Regulation
Potential of New Approach Methods to delineate between developmental and adult neurotoxicity hazard
TG+ Enniatin B1
Nanomaterials: applicability of New Approach Methodologies and assessment of baseline toxicity
Structured toxicological data and computer models to support next-generation chemical risk assessment
Studying the effects of pollutants on molting in arthropods
Studying the reliability of alternatives to fish toxicity testing of chemicals
Accumulation of microplastics and plastic additives in aquatic organisms and the potential of in vitro methods
Toxicity of water-soluble plastics: original form and changes due to environmental processes
Environment
Health effects
Human health
Monitoring methods
Risk assessment
NGRA
Mixtures
Human biomonitoring
Workers
Accumulation of microplastics and plastic additives in aquatic organisms and the potential of in vitro methods
Toxicity of water-soluble plastics: original form and changes due to environmental processes
Accumulation of microplastics and plastic additives in aquatic organisms and the potential of in vitro methods
Closing data gaps in PBK modelling for endocrine-disrupting chemicals (EDCs)
Effect-specific risk assessment reviews
Follow-up Immunotoxicity
Further development of an IATA for Metabolic Disruption
Improving computer models that simulate the behaviour of chemicals in the human body across different life stages
Integrated approaches to testing and assessment (IATA) for carcinogenicity
Making Adverse Outcome Pathways (AOPs) ready for use under EU Regulation
Nanomaterials: applicability of New Approach Methodologies and assessment of baseline toxicity
Potential of New Approach Methods to delineate between developmental and adult neurotoxicity hazard
Structured toxicological data and computer models to support next-generation chemical risk assessment
Studying the effects of pollutants on molting in arthropods
Studying the reliability of alternatives to fish toxicity testing of chemicals
TG+ Enniatin B1
Toxicity of water-soluble plastics: original form and changes due to environmental processes
Bridging data gaps for some Alternaria toxins
Closing data gaps in PBK modelling for endocrine-disrupting chemicals (EDCs)
Effect-specific risk assessment reviews
Environmental burden of disease and health impact of chemicals
Follow-up Immunotoxicity
Further development of an IATA for Metabolic Disruption
Hazard characterization and closing data gaps of emerging mycotoxins
Improving computer models that simulate the behaviour of chemicals in the human body across different life stages
Improving the transfer and use of information on chemicals in products
Innovative approaches to soil contaminant assessment
Integrated approaches to testing and assessment (IATA) for carcinogenicity
Making Adverse Outcome Pathways (AOPs) ready for use under EU Regulation
Potential of New Approach Methods to delineate between developmental and adult neurotoxicity hazard
Risk assessment of chemical mixtures measured in the human body
TG+ Enniatin B1
Tools, criteria, and methods used in risk assessment reviews
Total human exposure to chemicals from multiple sources and settings
Bridging data gaps for some Alternaria toxins
Environmental burden of disease and health impact of chemicals
Hazard characterization and closing data gaps of emerging mycotoxins
Innovative approaches to soil contaminant assessment
Risk assessment of chemical mixtures measured in the human body
Studying persistent, mobile and toxic chemicals in soil, water and air across Europe
Tools, criteria, and methods used in risk assessment reviews

In vitro methods to assess respiratory uptake and toxicity

Time span
-
Potential impacts
  • A guidance document on dosimetry and the use of respiratory in vitro models for uptake assessment;
  • Further development of a biokinetic model to determine respiratory uptake
  • Standardisation of methods to assess respiratory uptake with in vitro models
RIVM (NL)
INERIS (FR)
VITO (BE)
ENSP (PT)
LIST (LU)
IRFMN (IT)
STAMI (NO)
UG-PL (PL)
AUTH (GR)
WU-TOX (NL)
Overview

Inhalation is an important but often not assessed route of chemical exposure, alongside dermal and oral pathways. This project addresses the current gap by developing in vitro models to assess how chemicals are absorbed, accumulated, and transported through respiratory tissues.

The focus is on two key chemical groups pesticides (e.g. pyrethroids) and per- and polyfluoroalkyl substances (PFAS) that are commonly encountered in occupational settings. Using data-rich chemicals with existing human in vivo data, the project will generate in vitro respiratory uptake data, develop biokinetic and QSAR models ↗, and refine physiologically based kinetic (PBK) models to estimate respiratory uptake. In vitro to in vivo extrapolation (IVIVE) ↗ will translate laboratory findings into real-world exposure levels.

This work aims to standardise in vitro respiratory models and dosimetry methods, enabling accurate evaluation of systemic effects from inhalation exposure. These advances will support regulatory risk assessments under frameworks such as REACH ↗ and OSHA, while contributing to reduced reliance on animal testing.

The project supports several PARC activities, including PFAS ↗ assessment, NAM ↗ development, endocrine disruptor mixtures, chronic toxicity modelling and read-across strategies. By delivering reliable tools and data, this initiative strengthens safety evaluations and enhances human health protection in industrial and environmental contexts.

Achievements & Results

The project has started in May 2025, the first activity is to identify data daps on air-liquid interface models’ dosimetry, in vitro biokinetic approaches and permeability models.

Policy relevance

This project will:

  • provide guidance for assessment of respiratory uptake of airborne substances;
  • enable regulatory implementation of NAM-based approaches focusing on inhaled exposure.
Contacts
Yvonne Staal (RIVM)
Yvonne.Staal [at] RIVM.nl
Tanja Hansen (Fraunhofer)
tanja.hansen [at] item.fraunhofer.de
Pierre-Andre Billat (INERIS)
Pierre-andre.BILLAT [at] ineris.fr
Topics
Provide protection against most harmful chemicals
Shift away from animal testing
Keywords
Human health
NGRA